header mRNA report 540x680
NICE INSIGHT REPORT

mRNA Vaccines & Therapeutics:
2023 Market Analysis, CDMO Pricing and Benchmarking

Coming July, 2023
  • 100 pages of research and market intelligence for your sales team
  • Over 60 mRNA vaccines & therapeutics CDMO profiles
  • 2023 mRNA manufacturing process and pricing comparison
  • Scientific analysis of mRNA production by KOLs
  • Market segment analysis by development stage
header mRNA report 540x680

Key market insights for innovators, CDMOs and investors in the mRNA industry.

01 analytics icon 65x65-1

Essential price benchmarking and market intelligence for CDMOs

Compare prices to your competitors with our strategic pricing study, which breaks down the manufacturing process and industry costs. As investments pour in from both the private and government sectors, learn from leaders in mRNA-based drugs so you can better position your business.
02 pipeline icon 65x65

Grasp the mRNA Vaccine & Therapeutics Pipeline

Our Market Analysis provides an in-depth R&D pipeline report segmented by indication and development stage. Make informed business decisions with our guide to approved mRNA drugs and the developmental and clinical landscape. See where your competitors are from pre-clinical through Phase III trials.

Coming July, 2023

Our Market Analysis combines data insights and interviews with prominent mRNA players so your sales team can unlock the booming industry.

The mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking provides

01 report icon 65x65-1
Strategic pricing study
that analyzes the manufacturing process and primary data
02 research icon 65x65
Over 60 CDMO profiles
which include segment, proprietary technologies and location
03 pie chart icon 65x65
Market intelligence
segmented by drug type and disease application
04 bar graph icon 65x65
Pipeline development mapping
for approved mRNA drugs and preclinical through phase III trials
05 data analytics icon 65x65
Investor insights
for one of the fastest growing markets in pharma
06 innovation icon 65x65
Unique benefits and complexities
to mRNA manufacturing that is invaluable to developers

Over 900 hours of data collection and analysis, with
invaluable insights from industry experts

Table of Contents

Executive Summary

Overview of the report

Study Methodology

Section I:

Background on mRNA Vaccine and Therapeutics

  • The rise of mRNA Technology
  • Impact of COVID in accelerating activity in the sector
  • National defense perspective
    • - Increased investment from private and government sectors
    • - Aging population and rise in cancer in young ages (Aggressive and difficult, also looking for noninvasive therapy for social activities)
    • - Strict approval of government for therapeutics

Section II:

mRNA Vaccine and Therapeutics Market Overview

  • 1. mRNA and its Therapeutic Applications
    • - Explanation of mRNA and what is unique about the modality.
    • - Overview of the development and therapeutic applications of mRNA-based drugs
    • - Comparison of mRNA-based drugs with other biologic drugs
    • - Advantages and disadvantages of mRNA-based drugs
  • 2. Market Segmentation by type
    • - Prophylactic Vaccines
    • - Therapeutic Vaccines
    • - Therapeutic Drugs
  • 3. Market Segmentation by disease application
    • - Oncology
    • - Infectious disease
    • - Rare genetic disease
  • 3. Market Segment analysis by development stage (Development mapping David presented) : Texts and figure
    • - Approved mRNA drugs and development and clinical landscape
    • - Preclinical
    • - Phase 1
    • - Phase 2
    • - Phase 3

Section III:

mRNA Manufacturing Technologies

  • Types of mRNA manufacturing technologies
  • LNP (Vehicle) CDMO
  • Starting product CDMO
  • Comparison of different mRNA manufacturing technologies
  • Advantages and disadvantages of each technology
  • Market share of each technology

Section IV:

Unique Considerations and Complexities in mRNA Development and Manufacturing

  • Overview of the unique considerations and complexities in mRNA development and manufacturing
  • Challenges in developing and manufacturing mRNA-based drugs, including stability, purity, potency, and immunogenicity
  • Impact of these challenges on the development and manufacturing process
  • Strategies and technologies used to overcome these challenges

Section V:

mRNA CDMOs Market Outlook

  • Market Overview
  • Growth drivers
  • Opportunities and challenges

Section VI:

Strategic Pricing Study

  • Manufacturing process
  • Strategic pricing

Section VII:

mRNA CDMOs Profile

  • Key segmentation analysis
  • Summary of Services
  • Individual profiles
mRNA report form
Coming July, 2023
Request your copy of the 2023 mRNA Vaccines and Therapeutics Report

mRNA report form